They may help us to develop new methods and medicine based on adropin and JAK2/STAT3 signaling to treat vascular calcification diseases, such as atherosclerotic disease, hypertension, diabetes, and chronic kidney diseases. This evidence concerns the gene STAT3 and diabetes mellitus.